vininews.com
vininews.com Veritas, Inquiry, News & Intelligence

Verified source report

Immunotherapy could be used to treat depression, early trial suggests

UK scientists find tocilizumab, used for rheumatoid arthritis, may help antidepressant-resistant patients Immunotherapy could be used to treat depression among patients who have not responded to conventional antidepressants, according to the results of an early clinical trial. Researchers at the University of Bristol investigated whether tocilizumab, an anti-inflammatory drug commonly used for immune conditions such as rheumatoid arthritis, could improve symptoms of difficult-to-treat depression. Continue reading...

Immunotherapy could be used to treat depression, early trial suggests
Source image associated with the linked report from The Guardian. Image selected from source feed metadata and displayed with attribution and link back; VINI does not copy the image into local storage unless rights are cleared.Credit: Image via The Guardian · Source-hosted image; rights remain with the publisher or credited rights holder. · Image source

Share

Send this story

Share the canonical link, post it to a feed, or send it directly.

X Facebook LinkedIn Reddit WhatsApp Email
Vinita Duniphin Science Source report

What happened

According to The Guardian’s source item, Immunotherapy could be used to treat depression, early trial suggests, UK scientists find tocilizumab, used for rheumatoid arthritis, may help antidepressant-resistant patients Immunotherapy could be used to treat depression among patients who have not responded to conventional antidepressants, according to the results of an early clinical trial. Researchers at the University of Bristol investigated whether tocilizumab, an anti-inflammatory drug commonly used for immune conditions such as rheumatoid arthritis, could improve symptoms of difficult-to-treat depression. Continue reading…

Context

The development sits in VINI’s Science file for readers following research, health, climate, space, medicine, and scientific institutions. The original report is linked so readers can check the source account, follow later updates, and compare new coverage against the first published record. The source item is dated 2026-05-20T15:00:47+00:00.

What to watch

Open questions include whether primary sources issue follow-up statements, whether local or market impacts become clearer, and whether additional reporting changes the timeline or adds material context.

Source

Primary source: Immunotherapy could be used to treat depression, early trial suggests via The Guardian. VINI cites and links the source; it does not reproduce the publisher’s full article text without rights clearance.

This source-cited VINI report links to the original publisher record. VINI does not republish third-party article bodies without rights clearance. 1 source listed.

Source links

Reader comments

Moderated discussion

Account access

Comments are open to authenticated approved accounts, screened for spam and abuse, and published only after newsroom moderation unless editors change the story control.

Loading comments.